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Phospholipase Cζ (PLCζ) is a sperm-specific PLC capable of causing repetitive intracellular Ca2+ ([Ca2+]i) release ([Ca
2+]i oscillations) in
mammalian eggs. Accumulating evidence suggests that PLCζ is the sperm factor responsible for inducing egg activation. Nevertheless, some
sperm fractions devoid of 72-kDa PLCζ showed [Ca2+]i oscillation-inducing and PLCζ-like PLC activity (Kurokawa et al., (2005) Dev. Biol. 285,
376–392). Here, we report that PLCζ remains functional after proteolytic cleavage at the X–Y linker region. We found that N-terminal (33 and
37 kDa) and C-terminal fragments (27 kDa), presumably the result of PLCζ cleavage at the X–Y linker region, were present in fresh sperm as well
as in sperm extracts and remained associated as functional complexes. Protease V8 cleaved 72-kDa PLCζ into 33/37 and 27 kDa fragments, while
PLC activity and [Ca2+]i oscillation-inducing activity persisted until degradation of the fragments. Immunodepletion or affinity depletion of these
fragments abolished PLC activity and [Ca2+]i oscillation-inducing activity from sperm extracts. Lastly, co-expression of cRNAs encoding residues
1–361 and 362–647 of mouse PLCζ, mimicking cleavage at the X–Y linker region, induced [Ca2+]i oscillations and embryo development in
mouse eggs. Our results support the hypothesis that PLCζ is the sole mammalian sperm factor and that its linker region may have important
regulatory functions during mammalian fertilization.
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kinaseIntroduction
In mammals, it is postulated that the fertilizing sperm
delivers into the ooplasm a soluble protein, termed sperm factor,
which evokes repetitive intracellular Ca2+ ([Ca2+]i) release, also
known as [Ca2+]i oscillations. These [Ca
2+]i oscillations induce
egg activation, which comprises a series of events including the
release of the cortical granules and the resumption of the cell
cycle and that ultimately leads to embryo development (Schultz
and Kopf, 1995; Ducibella et al., 2002). Earlier studies have⁎ Corresponding author. Fax: +1 413 545 6326.
E-mail address: rfissore@vasci.umass.edu (R.A. Fissore).
1 Current address: Department of Pharmacology and Cancer Biology, Duke
University Medical Center, Box 3813, Durham, NC 27710, USA.
0012-1606/$ - see front matter © 2007 Elsevier Inc. All rights reserved.
doi:10.1016/j.ydbio.2007.09.040shown that the sperm factor induces [Ca2+]i oscillations by
stimulating production of inositol 1,4,5-trisphosphate (IP3), an
event that requires the participation of a phospholipase C (PLC)
(Dupont et al., 1996; Jones et al., 1998; Rice et al., 2000). IP3
binds and gates IP3 receptors (IP3Rs), which are located in the
endoplasmic reticulum, the internal Ca2+ store of eggs, thereby
inducing Ca2+ release. Consistent with this proposed sequence
of events, treatment of eggs with a PLC inhibitor (Dupont et al.,
1996; Wu et al., 2001) or abrogation of IP3R-1 function
(Miyazaki et al., 1992; Wu et al., 1997) prevents the initiation of
[Ca2+]i oscillations. However, given that both sperm and eggs
express several PLC isoforms, it has remained controversial
whether the sperm factor is a sperm PLC or is an activator of an
egg PLC (for a review, see Kurokawa et al., 2004a). Toward
resolving this issue, the recent discovery of the sperm-specific
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findings that injection of PLCζ recombinant protein or of its
cRNA into eggs initiates sperm-like [Ca2+]i oscillations
(Saunders et al., 2002; Kouchi et al., 2004) and that its
immunodepletion from cytosolic sperm extracts abolishes the
ability of these extracts to cause oscillations (Saunders et al.,
2002), has solidified the view that the sperm factor in mammals
is a sperm PLC. However, whether PLCζ represents the only
active component in all mammalian sperm/sperm extracts
requires additional investigation.
The sperm-specific PLCζ is one of the smallest of the known
PLCs consisting of only four EF-hands, the catalytic X- and Y-
domains, and a C2 domain (Fig. 1A), all of which are common
to the other PLC isoforms (β, γ, δ, ε and η). Besides the absence
of the pleckstrin homology (PH) domain, the most salient
feature of PLCζ is the exceptionally high Ca2+ sensitivity of its
enzymatic activity; the enzyme is ∼100-fold more sensitive to
Ca2+ than PLCδ whose activity is also regulated by Ca2+
(Kouchi et al., 2004). Accordingly, PLCζ should be active at the
basal [Ca2+]i concentrations prevailing in cells, ∼100 nM,
which is consistent with the view that it serves as the initiator of
oscillations at fertilization. Nevertheless, it is still unclear what
molecular determinants of PLCζ confer such a high Ca2+
sensitivity, although mutational studies have revealed that both
EF-hand and C2 domains, where important Ca2+-binding sites
are located, are required for full activation of PLCζ (Kouchi et
al., 2005; Nomikos et al., 2005). Likewise, it is unknown how
the activity of the enzyme is regulated in vivo. Provided that
PLCζ is active at resting [Ca2+]i levels, it seems important that
its enzymatic activity be carefully controlled prior to interaction
of the gametes so that premature acrosome reaction is averted.
In this regard, Miyazaki and co-workers recently showed that in
vitro PLCζ activity is diminished by interaction of the C2
domain with PI(3)P and PI(5)P, although the physiological
relevance of this mechanism remains to be tested (Kouchi et al.,
2005).
We have previously demonstrated that two sperm fractions
(SF), the cytosolic fraction (SFC) and the high-pH soluble
fraction (SFpH), can be obtained by conventional sonication/
freeze-thawing and biochemical processing of porcine (p)
sperm (Kurokawa et al., 2005); both SFs were equally capable
of triggering [Ca2+]i oscillations and activation when micro-
injected into mouse eggs. To our surprise, although both SFC
and SFpH showed PLCζ-like in vitro PLC activity, immuno-
bloting studies revealed that only trace amounts of full-length
PLCζ (72-kDa PLCζ) were present in SFpH compared to SFC
(Kurokawa et al., 2005). Moreover, additional chromatographic
processing of these fractions showed that other active fractions
also lacked 72-kDa PLCζ (Kurokawa et al., 2005). Hence, we
envisioned two possibilities: (1) there is an unidentified sperm-
specific PLC isoform that also contributes to the sperm-induced
[Ca2+]i oscillations; or (2) PLCζ undergoes some kind of post-
translational modification, such as proteolytic cleavage, which
disables its immunological detection but not its phosphoinosi-
tide-hydrolyzing activity. In the present study, we show
evidence that PLCζ remains functional even after proteolytic
cleavage at the linker region that connects the X- and Y-domains. Both SFC and SFpH contain N-terminal and C-
terminal PLCζ fragments that form functional complexes as
their depletion abrogates [Ca2+]i oscillation-triggering activity
as well as PLC activity from SFpH fractions. Moreover, SFC
treated with Staphylococcus aureus protease V8 retains the
ability to induce [Ca2+]i oscillations even after 72-kDa PLCζ,
but not the fragments, is no longer detectable by immunoblot-
ing. We also found that co-expression of cRNAs encoding
residues 1–361 and 362–647 of mouse PLCζ (mPLCζ), which
approximates cleavage of the linker region, induces [Ca2+]i
oscillations and embryo development in mouse eggs. Collec-
tively, our results confirm that PLCζ is the only molecule in our
sperm extracts capable of inducing [Ca2+]i oscillations and
further show that its proteolytic processing may play a role
during mammalian fertilization.
Materials and methods
Gamete collection
Eggs at the second stage of meiosis (MII) were obtained from CD1 female
mice (8–12 weeks old) superovulated by injection of 5 IU of pregnant mare
serum gonadotropin (PMSG; Sigma, St. Louis, MO) followed 48 h later by 5 IU
of human chorionic gonadotropin (hCG; Sigma). Eggs were harvested 14 h post-
hCG into a Hepes-buffered tyrode–lactate solution (TL-Hepes) supplemented
with 5% heat-treated calf serum (Parrish et al., 1988). Cumulus cells were
removed by brief treatment with 0.1% bovine testes hyaluronidase (Sigma).
Porcine sperm were collected from freshly ejaculated semen and were
immediately washed two times either with injection buffer (IB: 75 mM KCl
and 20 mM HEPES, pH 7.0) for sperm extract preparation or with TL-Hepes for
immunoblotting.
All procedures involving live animal handling and euthanasia were
performed according to standard animal protocols approved by the University
of Massachusetts Animal Care Committee.
Preparation of porcine sperm extracts
SFC was prepared as previously described (Wu et al., 2001). Briefly, after
washing, the sperm suspension was sonicated in sperm buffer (75 mM KCl,
20 mM Hepes, 1 mM EDTA, 10 mM β-glycerophosphate, 1 mM DTT, 200 μM
PMSF, 10 μg/ml pepstatin, 10 μg/ml leupeptin, pH 7.0) at 4 °C and the lysate
ultracentrifuged. The clear supernatant was concentrated with ultrafiltration
membranes (Centriprep-30; Amicon, Beverly, MA). These extracts were then
mixed for 30 min at 4 °C with ammonium sulfate at 50% final saturation; the
precipitates were collected by centrifugation and kept at −80 °C. Upon use, the
pellets were resuspended with IB, washed and re-concentrated with ultrafiltra-
tion membranes.
SFpH was obtained as we reported previously (Kurokawa et al., 2005). In
brief, after sonication, the porcine sperm pellets were washed with sperm buffer
twice and then once with sperm buffer containing 1 M KCl. The resulting pellets
were treated with 100 mM Na2CO3 (pH 11.5). After the treatment, the sperm
suspension was neutralized, dialyzed against IB and concentrated. Samples were
aliquoted and kept at −80 °C.
cDNA constructs
Full length mPLCζ (mPLCζ WT; Accession No. AF435950), a variant
lacking three N-terminal EF-hand domains (mPLCζ ΔEF; Accession No.
AK006672), and the regions corresponding to residues 248–647, 362–647 and
454–647 of mPLCζ were amplified by PCR. The regions corresponding to
residues 1–557 (mPLCζ ΔC2), 1–247, 1–361 and 1–453 of mPLCζwere made
by introducing a stop codon to the respective sites of mPLCζ WT using the
QuikChange mutagenesis kit (Stratagene, La Jolla, CA). Likewise, D210R and
S405A mutations were generated using the QuikChange kit according to the
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pCS2-MT plasmids (Turner and Weintraub, 1994) using EcoRI and XbaI sites;
pCS2-MT has 6 repeats of myc-tag sequence at the 5′ end of MCS. cRNAs were
produced as previously described (Fissore et al., 1996). In brief, the cDNAs
were linearized at the NotI site and transcribed in vitro using the mMessage/
mMachine capping kit (Ambion, Austin, TX). Capped and poly(A)-tailed
cRNAs were purified from the reaction mixture using the MEGAclear Kit
(Ambion). The cRNAs were eluted with DEPC-treated H2O and, if necessary,
further diluted with it before microinjection.
Transfection
Cos-7 cells were grown in RPMI medium with 10% FBS, Pen/Strep and
2 mM L-glutamine. One day prior to transfection, cells were seeded onto 12 well
plates at 30% confluence. Transfections were performed using 0.5 μg of the
selected plasmid DNA per well and 1.5 μl of FuGENE6 (Hoffmann-La Roche,
Nutley, NJ) as per manufacturer’s instruction. Transfected cells were grown for
48 h, washed with PBS and extracted directly into Laemmli sample buffer
(200 μl/well); 10 μl was loaded per lane.
Microinjections and Ca2+ measurements
Microinjection procedures were as previously described (Wu et al., 2001). In
brief, eggs from CD-1 mice were microinjected using Narishige manipulators
(Medical Systems Corp., Great Neck, NY) mounted on a Nikon Diaphot
microscope (Nikon Inc., Garden City, NY). Glass micropipettes were filled by
suction from a microdrop containing SFs or cRNAs. Solution was expelled into
the cytoplasm of eggs by pneumatic pressure (PLI-100, picoinjector, Harvard
Apparatus, Cambridge, MA). The injection volume was approximately 5–10 pl
and resulted in a final intracellular concentration of the injected compounds of
approximately 1–2% of the concentration in the injection pipette.
Ca2+ measurements were carried out as previously described (Kurokawa
et al., 2005). Eggs were loaded with 1 μM Fura-2 acetoxymethylester (Fura-2
AM; Molecular Probes, Eugene, OR) supplemented with 0.02% pluronic acid
(Molecular Probes) for 20 min at room temperature. [Ca2+]i values were
monitored using a Nikon Diaphot microscope fitted for fluorescence
measurements. Two to fifteen eggs were simultaneously monitored using the
software Image 1/FL (Universal Imaging, Downington, PA). Images were
acquired using an SIT camera (Dage-MTI, Michigan City, IN) coupled to an
amplifier (Video Scope International Ltd., Sterling, VA). [Ca2+]i values were not
calibrated in this system and are therefore reported as the ratios of 340/380 nm
fluorescence. Fluorescence ratios were obtained every 10–20 s depending on
the experiment.
Western blotting and immunoprecipitation
Anti-PLCζ rabbit sera were raised against a 19-mer sequence at the N-
terminus of pPLCζ (anti-PLCζ-NT) or a 19-mer sequence at the C-terminus of
mPLCζ (anti-PLCζ-CT) (Kurokawa et al., 2005) (Fig. 1A). The antisera used
were affinity-purified using the antigenic peptides. The monoclonal antibody
(9E10; Santa Cruz Biotechnology, Santa Cruz, CA) was used for detection of
myc-tagged proteins.
Protein samples were separated by SDS–polyacrylamide gel electrophoresis
and, thereafter, transferred onto polyvinylidene difluoride membranes (Millipore
Corporation, Bedford, MA). Following incubation with non-fat dry milk (6%),
the membranes were probed with a primary antibody followed by a horseradish
peroxidase-labeled secondary antibody (Bio-Rad Laboratories, Hercules, CA).
Immunoreactivity was detected using chemiluminescence reagents (NEN Life
Science Products, Boston, MA) and the Kodak Image Station 440CF (NEN Life
Science Products). Western blotting procedures were repeated at least five times
for each sample and the representative pictures are shown in the figures.
For immunoprecipitation, pre-immune control antibody or anti-PLCζ-NT
antibody prebound to protein A sepharose beads (Sigma) was mixed with 50 μg
sperm protein in lysis buffer (20 mM Tris–HCl, 150 mM NaCl and 0.1% Triton
X-100, pH 7.6) and incubated at 4 °C for 6 h. After the beads were separated
from the supernatant by a short centrifugation (1000×g for 1 min), the
supernatant was either subjected directly to microinjection, PLC assay or towestern blotting. The bead pellet was washed three times with lysis buffer
containing 300 mM NaCl and three times with lysis buffer and subjected to
western blotting.
Peptides and affinity pull-down
Peptides A7 (SDSIQAEEWYFGKITRRE) and A9 (SDSIQAEEWYFG-
KIT) were prepared as previously described (Fukami et al., 1993) and
biotinylated at the N-terminal end of each peptide (B-A7 and B-A9). The
biotinylated peptides were dissolved in IB at 1 mM and kept at −80 °C until use.
Further dilutions were performed to obtain working concentrations.
Affinity pull-down experiments were performed for 15 min at 4 °C by
mixing 25 μl of SFC or SFpH (1.0 μg/μl) with 25 μl of either B-A7 or B-A9 to
obtain final peptide concentrations of 50, 100 or 200 μM. Following addition of
10 μl of 50% avidin beads (Pierce Biotechnology, Rockford, IL), the combined
mixture was further incubated for 15 min at 4 °C. The suspension was then
centrifuged at 1000×g for 1 min and, thereby, separated into supernatant (Sup)
and pellet fractions. The supernatants were either injected into mouse eggs to
monitor [Ca2+]i responses or subjected to immunoblotting, whereas the pellets
were subjected to immunoblot analyses. In some experiments, pellets were
further washed with IB and then mixed with equal amounts of IB supplemented
with 2 M KCl (pH 7.0) after which these supernatants containing high salts (Sup
II) were either microinjected into mouse eggs or used for immunoblotting. The
remaining pellet (Pellet II) was washed with IB and used for immunoblotting.
PLC assays
In vitro PLC assays were carried out based on the method previously
described (Liu et al., 1996; Kurokawa et al., 2005). In brief, 20 μl (1 to 20 μg) of
a sample was mixed with 30 μl of substrate cocktail to obtain a final
concentration of 50 μM phosphatidylethanolamine (Sigma), 40 μM PIP2
(Sigma), 0.01 μCi/50 μl [3H]PIP2 (PerkinElmer Life Sciences Inc., Boston,
MA), 25 mM MES (Sigma, pH 6.3), 1.0 mg/ml BSA, 2 mM EGTA and
100 nM Ca2+. The reaction proceeded for 5 min at room temperature and was
stopped by addition of 2 ml chloroform/methanol (2:1; v/v). The generated IP3
was separated into the upper aqueous phase by addition of 0.5 ml of 1 N HCl
and radioactivity was measured with a liquid scintillation counter (Beckman,
Fullerton, CA).
Protease V8 treatment
S. aureus protease V8 (Calbiochem, San Diego, CA) was dissolved in
50 mMNa3PO4 (pH 7.8). For V8 treatment of SF
C, 50 μg of SFC (0.5 μg/μl) was
mixed with 1 μg of V8 and incubated at 37 °C for various times. At each time
point, the mixture was injected to mouse eggs or subjected to PLC assay or
western blotting.Results
Immunodepletion of PLCζ fragments from SFpH abrogates the
fraction’s PLC activity and the ability to trigger [Ca2+]i
oscillations
We have previously shown that 72-kDa PLCζ was present in
freshly collected porcine sperm and in SFC, but not in SFpH
(Fig. 1B), even though both SFs showed high PLCζ-like
activity and induced [Ca2+]i oscillations in mouse eggs
(Kurokawa et al., 2005). Importantly, despite the absence of
72-kDa PLCζ from SFpH, lower, strongly immunoreactive
products, most likely the result of partial PLCζ proteolysis,
were commonly found in this fraction as well as in SFC and in
preparations from fresh live sperm (Fig. 1B). Therefore, we
reasoned that the PLCζ-like activity in SFpH, and perhaps also
Fig. 1. N- and C-terminal PLCζ fragments form stable complexes. (A) Schematic representation of PLCζmain domains: EF-hands, X- and Y-catalytic, X–Y linker and
C2 domain. Two antibodies, anti-PLCζ-NT and anti-PLCζ-CT, were raised against the N- and C-terminal end of PLCζ, respectively. (B) Western blotting using anti-
PLCζ-NT (left panel) and anti-PLCζ-CT (right panel) shows that 72-kDa PLCζ is present in fresh live sperm as well as in SFC, but is absent in SFpH (arrows). PLCζ
fragments are present in all samples (arrowheads: p27, p33, p35, p37, p42 p50). C and D, SFC (C) and SFpH (D) were precipitated (IP) with a control antibody (control)
or with anti-PLCζ-NT (PLCζ-NT). The resulting supernatants (Sup in upper panels) and pellet (lower panels) were used for immunoblotting (anti-PLCζ-NT, left panel;
anti-PLCζ-CT, right panel). Arrows and arrowheads indicate 72-kDa PLCζ and its fragments; the fragments most commonly and consistently seen (see text) are shown
in bold. Asterisks indicate IgG heavy chains.
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PLCζ fragments. To test this hypothesis, we performed
immunoprecipitation of PLCζ in SFC and SFpH and examined
whether depletion of 72-kDa PLCζ and/or of its fragments
removed the [Ca2+]i oscillation-inducing activity and PLC
activity from the fractions. Immunoprecipitation was carried out
with the anti-PLCζ-NT antibody and depletion was confirmed
by immunoblotting of the resulting supernatants and pellets
with the anti-PLCζ-CT as well as with the anti-PLCζ-NT
antibody (Fig. 1A). Incubation of SFC with the anti-PLCζ-NT
antibody prebound to protein A sepharose beads depleted 72-
kDa PLCζ from the supernatant fractions and caused concen-tration of it in the pellet fractions; incubation with pre-immune
control antibody failed to precipitate 72-kDa PLCζ (Fig. 1C).
When SFpH was subjected to the same treatment, as expected,
the 72-kDa PLCζ was not precipitated, as it was absent from
these fractions (Fig. 1D), supporting our previous observation
that SFpH contains only negligible amounts of 72-kDa PLCζ
(Kurokawa et al., 2005). Instead, three fragments were
specifically precipitated in this fraction; two of the fragments,
33 and 37 kDa, were recognized by the anti-PLCζ-NT antibody
in immunoblots and thought to represent N-terminal PLCζ
fragments, and a 27-kDa fragment that was detected by the anti-
PLCζ-CT antibody and thought to represent a C-terminal PLCζ
411M. Kurokawa et al. / Developmental Biology 312 (2007) 407–418fragment (Fig. 1D, left and right panels, respectively). The fact
that the anti-PLCζ-NT antibody precipitated both N- and C-
terminal PLCζ fragments suggests that they exist as stable
complexes in the sperm fractions. Importantly, these complexes
retained enzymatic activity because their depletion obliterated
the ability of SFpH fractions to induce [Ca2+]i oscillations in
mouse eggs (Fig. 2A) and nearly abolished their in vitro PLC
activity (Fig. 2B). Similar effects were observed in SFC devoid
of 72-kDa PLCζ and of its fragments (data not shown).
Interestingly, fresh sperm and SFC showed an additional N-
terminal fragment of approximately 42 kDa; the functional
significance of this fragment remains untested (Figs. 1B and C).
Also note that there were additional C-terminal fragments of
PLCζ at 35 and 50 kDa (Fig. 1B right panel). However, we
noticed that these fragments were not consistently detected in
the sperm fractions (see Fig. 1C right panels). Moreover, these
fragments were not co-precipitated with anti-PLCζ-NT anti-
body (Fig. 1D right panels). Therefore, we concluded that 35-
and 50-kDa fragments did not significantly participate in PLC
activity of the sperm fractions. Taken together, these results
suggest that N- (33 and 37 kDa) and C-terminus (27 kDa) PLCζ
fragments form stable complexes and that they retain in vitro
PLC enzymatic activity.
V8-treated PLCζ retains in vitro PLC activity and the ability to
induce [Ca2+]i oscillations
To further investigate whether or not PLCζ fragments retain
PLC activity and are capable of triggering [Ca2+]i oscillations in
mouse eggs, we performed limited proteolysis of 72-kDa PLCζ
present in SFC followed by monitoring of the remaining activity
in these fractions. Prior to selecting a protease, we estimated
where the cleavage of PLCζ was taking place in our fractions.
Previous reports have shown that the region connecting the X-
and Y-catalytic domains, the linker region, of PLC is susceptible
to proteolysis (Ellis et al., 1993; Fernald et al., 1994; Schnabel
and Camps, 1998). This information, together with the size of
the N- and C-terminal fragments in our fractions of ∼33/37 and
27 kDa, respectively, leads us to suspect that PLCζ might be
cleaved within this region. Consequently, we selected S. aureus
protease V8 as it selectively cleaves peptide bonds on theFig. 2. Immunodepletion of PLCζ fragments depletes the ability of SFpH to trigger [Ca
immunodepletion using a control antibody (left panel) or anti-PLCζ-NT (right panel
monitored. Mock-depleted SFpH (control IgG) triggered [Ca2+]i oscillations in all of
induce any Ca2+ rise (numbers in parentheses indicate the number of eggs that exhibite
after immunodepletion. PLC activity is shown relative to that of untreated SFpH (thecarboxyl side of Asp and Glu residues, both of which are
enriched in the linker region of pPLCζ (Yoneda et al., 2006).
Moreover, V8 has been previously shown to preferentially
cleave the X–Y linker region of other PLC isoforms (Fernald et
al., 1994; Schnabel and Camps, 1998). Treatment of SFC with
protease V8 led to a rapid digestion of 72-kDa PLCζ, which
became almost undetectable within 30 min post-treatment (Fig.
3A). Conversely, the immunoreactivity of the 33 and 37 kDa N-
terminal fragments and that of the 27 kDa C-terminal fragment
remained steady or even increased during this time (Fig. 3A),
suggesting that V8 was cleaving 72-kDa PLCζ at sites similar to
those targeted by the endogenous proteases. Importantly, V8-
treated SFC fractions were still capable of inducing [Ca2+]i
oscillations in mouse eggs for more than 60 min after the
treatment (Fig. 3B). Likewise, in vitro PLC activity of SFC
remained unchanged for the first 30 min of V8 treatment and
then gradually decreased (Fig. 3C). Importantly, after 60 min,
the immunoreactivity of the V8-generated PLCζ fragments also
became undetectable, which coincided with the demise of both
[Ca2+]i oscillation-inducing activity and PLC activity of the
SFC fractions (Figs. 3A–C).
Peptide A7 binds to PLCζ/PLCζ fragments and inhibits in vitro
PLC activity in SFpH
We have previously shown that pre-incubation of SFC
extracts with peptide A, an Src-family kinase (SFK) specific
inhibitor, blocked the ability of these extracts to trigger [Ca2+]i
oscillations in mouse eggs whereas a control peptide, peptide
A9, was without effect (Kurokawa et al. 2004b). However,
whether this was due to inhibition of an SFK-mediated pathway
was unclear as only high concentrations of peptide A
(∼200 μM) were effective and other SFK inhibitors, such as
Lavendustin A and PP2, were unable to block SFC-induced
[Ca2+]i oscillations (Kurokawa et al. 2004b). Given the
difference in electrostatic charge between peptides A and A9
(Fig. 4A), and considering the wealth of charged residues in the
linker region of pPLCζ (Yoneda et al., 2006), we reasoned that
peptide A could be inhibiting SFC-mediated oscillations by
interacting with PLCζ and/or its fragments. Therefore, to gain
more insight into the mechanism of action of peptide A, we2+]i oscillations and abrogates its in vitro PLC activity. (A) SF
pH was subjected to
) and the supernatants injected (arrows) into mouse eggs. [Ca2+]i changes were
the mouse eggs injected, while PLCζ fragments-depleted SFpH (PLCζ) did not
d oscillations and the number of eggs injected). (B) In vitro PLC activity of SFpH
error bars indicate standard deviation (n=3)).
Fig. 3. Limited proteolysis of SFC by protease V8. (A) Protease V8 (10 ng/μl) was mixed with SFC (0.5 μg/μl) and samples taken at different time points. Western
blotting using anti-PLCζ-NT (left panel) and anti-PLCζ-CT (right panel) shows that 72-kDa PLCζ (arrow) was cleaved to smaller, endogenous-like fragments present
in SFpH (arrow heads: p27, p33, p37). (B) Samples as from panel Awere injected (arrows) into mouse eggs and monitored for [Ca2+]i changes (numbers in parentheses
indicate the number of eggs tested). V8 treatment of SFC for up to 60 min did not alter the pattern of [Ca2+]i oscillations (compare between time 0 and 60 min).
Nonetheless, SFC incubated with V8 for 120 min triggered only 1 to 3 Ca2+ spikes (the large first Ca2+ rise followed by 0–2 small and short rises), while SFC incubated
with V8 for 180 min no longer induced any Ca2+ rise. The most representative Ca2+ patterns obtained were shown. (C) Samples from panel Awere tested for in vitro
PLC activity. Averages in PLC activity with standard deviation are shown (n=10).
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differs from the inactive peptide A9 by 3 charged amino acids
(Arginine–Arginine–Glutamic acid) in the C-terminal end (Fig.
4A). We first confirmed that peptide A7 was as effective as
peptide A in inhibiting [Ca2+]i oscillations induced by injection
of both SFC and SFpH into mouse eggs (data not shown). We
then performed in vitro PLC assays to test that peptide A7, but
not A9, caused a dose-dependent decrease in PLC activity in
both SFC (data not shown) and SEpH (Fig. 4B). Lastly, we
evaluated whether peptide A7 binds to the 72-kDa PLCζ and/or
its fragments. Accordingly, incubation of SFC and SFpH with
biotinylated versions of the peptides, B-A7 or B-A9, followed
by precipitation with avidin beads resulted in precipitation of
72-kDa PLCζ as well as of its smaller fragments in a
concentration-dependent manner by B-A7 but not by B-A9
(Fig. 4C; also see Fig. 5C). Correspondingly, the depletion of
72-kDa PLCζ and its fragments by 200 μMB-A7 abrogated the
ability of sperm extracts to trigger [Ca2+]i oscillations (Fig. 4D).Given that the association between peptide A7 and PLCζ/
PLCζ fragments is likely mediated via opposite ionic charges in
the molecules, increasing the ionic concentration of the solution
should interfere with the interaction of the molecules and lead to
the recovery of PLCζ/PLCζ fragments and [Ca2+]i oscillation-
inducing activity into the supernatants (Sup II; see Fig. 5A).
Consequently, injection of Sup II, which was obtained after
incubation of B-A7/SFpH pellets with IB supplemented with
2 M KCl (Fig. 5A), resulted in [Ca2+]i oscillations in all tested
eggs (Fig. 5B). Importantly, this treatment also resulted in the
partial recovery of PLCζ fragments (p27, p33, p37) into Sup II
(Fig. 5C). In contrast, supernatants obtained after treatment of
B-A7 pellets with IB without additional KCl supplementation
failed to trigger any [Ca2+]i responses (Fig. 5B). Likewise, KCl
treatment of B-A9 pellets did not release [Ca2+]i oscillation-
inducing activity (Fig. 5B) nor did this treatment release PLCζ
fragments into Sup II (Fig. 5C). Together, these results suggest
that peptide A7 exerts its inhibitory effect on sperm extracts by
Fig. 4. Peptide A7 binds to 72-kDa PLCζ and its fragments and inhibits in vitro
PLC activity. (A) Amino acid sequences of peptides A, A7 and A9 are shown.
Peptide A7 is a more specific analogue of peptide A and lacks three amino acids
at the N-terminal end of peptide A, whereas peptide A9, the inactive analogue,
lacks three amino acids at each end of peptide A. The ability of each peptide to
inhibit Src family kinases (Fukami et al., 1993) also is indicated. (B) In vitro
PLC assays reveal that peptide A7 significantly inhibits SFpH PLC activity
compared to its inactive control, peptide A9. Shown are means with standard
deviation (n=4). The asterisks indicate Pb0.05 (Student's t-test). Panels C and
D, biotinylated peptide A7 (B-A7) binds to and precipitates PLCζ and its
fragments after addition of avidin beads. SFC and SFpH were pre-incubated with
B-A7 followed by avidin bead precipitation, and the resulting supernatant (Sup)
and pellet were subjected to immunoblotting (C) and microinjection into mouse
eggs (D). Immunoblotting with anti-PLCζ-CT antibody shows that 72-kDa
PLCζ (arrows) and its fragments, especially p27 (arrowheads), were precipitated
by B-A7 in a dose-dependent manner, but not by B-A9 (C). The removal of the
[Ca2+]i oscillation-inducing activity from both SF
C and SFpH upon B-A7/avidin
precipitation also was dose dependent, whereas pre-incubation with B-A9 had
no effect (D).
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our immunodepletion data showing that the 33/37-kDa and 27-
kDa fragments form a functional PLC complex.
Co-expression of mPLCζ (1–361) and mPLCζ (362–647)
triggers [Ca2+]i oscillations as well as egg activation and
embryo development
To ascertain which PLCζ fragment(s) was responsible for
triggering [Ca2+]i oscillations in eggs, we generated various
mutants of mPLCζ (Fig. 6) and expressed their cRNAs in
mouse eggs. Expression of wild type mPLCζ cRNA (mPLCζ
WT) induced [Ca2+]i oscillations within 1 h in all injected eggs
(Fig. 7A). In contrast, microinjection of cRNAs that lacked
either the region encoding the three most N-terminal EF-hand
domains (mPLCζ ΔEF; Fig. 6) or a part of the C2 domain
(mPLCζ ΔC2; Fig. 6) failed to induce any [Ca2+]i responses
(Figs. 7B and C). As expected, none of the eggs injected with
mPLCζ ΔEF or mPLCζ ΔC2 cRNA showed signs of egg
activation, whereas nearly all eggs injected with mPLCζ WT
cRNA were activated (Table 1). These results are consistent
with previous reports (Saunders et al., 2002; Kouchi et al.,
2005; Nomikos et al., 2005) indicating that both EF-hand and
C2 domains are required for PLCζ to achieve maximal
enzymatic activity.
Next, we tested whether co-expression of two cRNAs
encoding different but complementary portions of mPLCζ
fragments, i.e. one cRNA encoded for an N-terminal fragment
and the other for a complementary C-terminal portion that
restored the full length of the molecule, was able to trigger
[Ca2+]i oscillations and egg activation. Expression of cRNAs
pairs encoding mPLCζ residues 1–247 and 248–647 or
residues 1–453 and 454–647 (Fig. 6) failed to induce [Ca2+]i
responses or egg activation (Figs. 7D and E and Table 1).
Remarkably, co-injection of cRNAs encoding mPLCζ residues
1–361 and 362–647 (Fig. 6) induced persistent [Ca2+]i
oscillations (Fig. 7F) and egg activation at similar rates to
those injected with mPLCζ WT cRNA (Table 1 and Fig. 8, top
panel, 6 h), whereas injection of either cRNA alone did not
induce any Ca2+ release (Figs. 7G and H) or egg activation
(Table 1). Furthermore, substitution of Asp210 with Arg (Fig.
6), which is known to abrogate PLC activity in mPLCζ
(mPLCζD210R in Fig. 7I and Table 1), abolished the ability of
the cRNA combination (mPLCζ (1–361)D210R+(362–647)) to
trigger [Ca2+]i oscillations and egg activation (Fig. 7J and
Table 1). Likewise, substitution of Ser405 by Ala (Fig. 6), which
also significantly decreases PLC activity (Ellis et al., 1998),
abolished the ability of mPLCζ (1–361)+ (362–647)S405A
cRNA combination to initiate [Ca2+]i oscillations and egg
activation (Fig. 7K and Table 1). To confirm that the mutant
constructs were indeed translated, we selected some of the
inactive constructs for transfection into Cos-7 cells. For
detection of the expressed proteins, the same expression vector
as above, but with the N-terminal myc-tag, was used, and
western blotting was performed with anti-myc-antibody.
mPLCζ ΔC2, which failed to induce Ca2+ release, was abun-
dantly expressed in these cells (Fig. 7L). Likewise, expression of
Fig. 5. KCl treatment of SFpH/B-A7 pellets co-releases [Ca2+]i oscillation-inducing activity and PLCζ fragments p27, p33 and p37. (A) [Ca
2+]i oscillation-inducing
activity from the B-A7/avidin SFpH pellet was recovered after washes with IB and after treatment with IB supplemented with 2 M KCl. After incubation on ice, the
supernatant (Sup II) was separated from the pellet (Pellet II) and subjected to microinjection (B) or immunoblotting (C). (B) Injection of Sup II following B-A7
precipitation and KCl treatment triggered [Ca2+]i oscillations in all tested mouse eggs (9 out of 9). In contrast, injection of Sup II from KCl-treated B-A9 pellets had no
effects. Likewise, injection of Sup II from B-A7 pellets treated with IB without additional KCl did not cause [Ca2+]i responses. (C) Immunoblotting with anti-PLCζ-NT
(left) and anti-PLCζ-CT antibodies (right) shows that KCl treatment of SFpH/B-A7 pellets partially released PLCζ fragments into Sup II, although detectable amounts
of the fragments still remained in Pellet II. PLCζ fragments are indicated by arrowheads (p27, p33 and p37).
Fig. 6. Schematic representation of wild type (WT) and mutant mPLCζ
constructs. WT and mutant versions of mPLCζ were generated and cRNAs
prepared (see Materials and methods). Where present, numbers indicate the first
and/or last amino acid within construct.
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clearly detected (Fig. 7L). Together, these results suggest that the
absence of [Ca2+]i responses after injection of these mutants was
due to inherent defects in enzymatic activity rather than to
defects in protein expression or stability.
Finally, the developmental potential of [Ca2+]i oscillations
initiated by co-expression of cRNAs encoding mPLCζ (1–361)
and mPLCζ (362–647) was ascertained. To maintain the diploid
status of parthenogenetic zygotes, following injection of the
cRNAs, eggs were cultured in the presence of cytochalasin B to
prevent extrusion of the second polar body. Injection of either
mPLCζ WT or co-injection of mPLCζ (1–361) and (362–647)
cRNAs resulted in similar cleavage rates to the 2-cell stage
(day 1) and development to the morula and blastocyst stage
(day 4; Table 2 and Fig. 8).
Discussion
The present study shows that PLCζ represents the sole Ca2+
active factor required for egg activation in porcine and most
likely in all mammalian sperm. While some pSFC and all pSFpH
were devoid of 72-kDa PLCζ (Kurokawa et al., 2005), all the
highly Ca2+ sensitive in vitro PLC and [Ca2+]i oscillatory
activity could be accounted for the presence of PLCζ fragments,
Fig. 7. Co-expression of mPLCζ (1–361) and mPLCζ (362–647) cRNAs triggers [Ca2+]i oscillations in mouse eggs. (A–K) cRNAs encoding WT and mutant PLCζs
prepared as above were produced and injected into mouse eggs. cRNAs were injected at 0.3 μg/μl (concentration in the pipette). (L) mPLCζ ΔC2 (lane 1), mPLCζ
(1–361)D210R (lane 2), mPLCζ (362–647)S405A (lane 3) with myc-tag were transfected to Cos-7 cells. Forty-eight hours later, cells were harvested and subjected to
SDS–PAGE followed by western blotting with anti-myc antibody. As a control, mPLCζ (362–647) without myc-tag was similarly treated and loaded in lane 4.
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affinity depletion of 72 kDa and/or of its fragments.
Furthermore, co-expression of cRNAs encoding complemen-
tary PLCζ fragments induced [Ca2+]i oscillations, egg activa-
tion and embryo development. Together, our results point to
PLCζ as the exclusive factor that underpins the fertilization-
associated [Ca2+]i oscillations in mammals and our data also
imply a critical regulatory role for the enzyme’s linker region
during fertilization.PLCζ is the putative sperm factor
In a previous study that characterized for the first time the
complete [Ca2+]i oscillation-inducing activity of a mammalian
sperm, we found that a fraction, the SFpH fraction, despite
lacking 72-kDa PLCζ, was capable of inducing [Ca2+]i
oscillations and egg activation of mouse eggs. Moreover,
SFpH exhibited prominent in vitro PLC activity, especially at
resting [Ca2+]i levels, which is a hallmark of PLCζ enzymatic
Table 1
Mouse egg activation following injection of mPLCζ cRNA constructs
cRNA constructs No. eggs
injected
No. activation
(%)
mPLCζ WT 65 59 (91)
mPLCζ ΔEF 30 0 (0)
mPLCζ ΔC2 54 0 (0)
mPLCζ (1–247)+mPLCζ (248–647) 21 0 (0)
mPLCζ (1–361)+mPLCζ (362–647) 69 69 (97)
mPLCζ (1–453)+mPLCζ (454–647) 21 0 (0)
mPLCζD210R 58 0 (0)
mPLCζ (1–361) 26 0 (0)
mPLCζ (362–647) 24 0 (0)
mPLCζ (1–361)D210R+mPLCζ (362–647) 32 0 (0)
mPLCζ (1–361)+mPLCζ (362–647)S405A 36 0 (0)
Egg activation was assessed by PN formation at 6 h post-injection. All cRNAs
were injected at 0.3 μg/μl (concentration in the pipette); when two different
cRNAs were injected, the total cRNA concentration in the pipette was of
0.6 μg/μl.
Table 2
Embryo development following injection of mPLCζ cRNAs into mouse eggs
cRNA constructs No. eggs
injected
No. eggs (%) developed to
PN 2-cell MO+BL BL
mPLCζ WT 14 14 (100) 14 (100) 10 (71) 4 (29)
mPLCζ (1–361)+
mPLCζ (362–647)
36 34 (94) 30 (83) 22 (61) 14 (39)
MO: morula.
BL: blastocyst.
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paradoxical results, here we examined whether fragments of
PLCζ could account for the [Ca2+]i oscillatory and PLC activity
in SFpH. Our present results demonstrate that, although SFpH
was devoid of 72-kDa PLCζ, it was endowed with several N-
and C-terminal PLCζ fragments. Moreover, we observed that
the 27-kDa C-terminal PLCζ fragment co-immunoprecipitated
with the 33-kDa and/or 37-kDa PLCζN-terminal fragments and
that depletion of these fragments exhausted the [Ca2+]i
oscillatory and in vitro PLC activity of SFpH. Similar resultsFig. 8. Co-expression of mPLCζ (1–361) and mPLCζ (362–647) cRNAs
induces egg activation and development. Mouse eggs injected with mPLCζ
WT cRNA or co-injected with cRNAs encoding mPLCζ (1–361) and mPLCζ
(362–647) extruded the second polar body and formed a female PN. cRNA-
injected eggs treated with cytochalasin B developed to the 2-cell stage (day 1)
and blastocysts (day 4).were observed with depletion experiments performed with B-
A7 peptides. Our results therefore demonstrate that all the
[Ca2+]i oscillation-inducing activity of porcine sperm can be
attributed to 72-kDa PLCζ and/or its N- and C-terminal
fragments, which remain associated and form a functional
complex. Our findings may also explain results from a
previous report in which the ability of porcine sperm fractions
to induce egg activation did not precisely coincide with the
presence of 72-kDa PLCζ (Fujimoto et al., 2004).
The X–Y linker region as a regulatory domain of PLCζ
function
The regulation of PLCζ function in vivo and the role of
each of its domains in this process remain to be fully
characterized. It is well known that both catalytic domains,
the X- and Y-domains, are indispensable for the enzymatic
activity of all PLC family members (Rebecchi and Pentyala,
2000). Regarding PLCζ, recent studies have shown that both
the EF-hand and C2 domains are also essential for enzymatic
activity as partial deletion of the N-terminal end or of the C-
terminal end of the molecule reduced the in vitro PLC
activity of respective recombinant proteins, as well as
abrogated the ability of corresponding cRNAs to trigger
[Ca2+]i oscillations upon injection into eggs (Kouchi et al.,
2005; Nomikos et al., 2005). Our results following expression
of mPLCζ ΔEF or mPLCζ ΔC2 cRNAs in mouse eggs
confirm those findings. In light of these results, it could be
envisaged that the formation of an active complex by PLCζ
fragments requires fragments with intact N- and C-terminal
ends and that each fragment includes an intact X- or Y-
domain; seemingly, these restrictions can be accommodated if
cleavage of PLCζ takes place between the X- and Y-domains.
Accordingly, co-expression of complementary PLCζ cRNAs
mimicking cleavage within the X- (mPLCζ (1–247)+mPLCζ
(248–647)) or the Y-domains (mPLCζ (1–453)+mPLCζ
(454–647)) failed to induce [Ca2+]i oscillations or egg
activation, whereas co-expression of cRNAs in which the
cleavage site was within the linker region (mPLCζ (1–361)
and mPLCζ (362–647)) triggered [Ca2+]i oscillations and
embryo development. Furthermore, the finding that the
estimated molecular weight of the polypeptides encoded by
mPLCζ (1–361) and mPLCζ (362–647) cRNAs is of ∼42
and 32 kDa, respectively, which are remarkably similar to
those of the endogenous N-terminal (∼33 and 37 kDa) and
C-terminal (27 kDa) fragments in SFs, supports the notion
that in vivo PLCζ cleavage takes place in the linker region.
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from our in vitro proteolytic studies using the protease V8,
which induced rapid disappearance of 72-kDa PLCζ from SFC
while promoting concomitant accumulation of polypeptides at
apparent molecular weights corresponding to the N- (33 and
37 kDa) and C-terminal (27 kDa) endogenous fragments. It
should be noted that given that the X–Y linker region spans
for ~70 amino acids in mouse and porcine PLCζs (residues
309–385 and 300–374, respectively), which represent∼9 kDa,
it seems likely that the fragments in SFs are produced by
multiple cleavages within this domain. Indeed, the total mole-
cular weights of the complexes estimated from respective
fragments (33+27=60 kDa, 37+27=64 kDa) suggest that such
cleavages may remove a large portion of the X–Y linker region.
The present demonstration that PLCζ fragments in sperm
and in SFs retain activity and are capable of inducing [Ca2+]i
oscillations is the first example that spontaneous proteolysis of
PLCs may play a physiological role in cellular function.
Importantly, earlier studies have demonstrated that the X–Y
linker domain of PLCβ, γ and δ isoforms was susceptible to in
vitro proteolysis, and those studies also found that the two
resulting PLC fragments, which remained associated and
formed a functional heterodimer, exhibited enhanced rather
than reduced PLC catalytic activity compared to the holoen-
zymes (Ellis et al., 1993; Fernald et al., 1994; Schnabel and
Camps, 1998). As a corollary, it was suggested that cleavage in
this domain might cause a conformational change in the tertiary
association of the X- and Y-domains, thereby facilitating
interaction and hydrolysis with the lipid substrates, or that it
might result in removal of part of the X–Y linker domain,
thereby facilitating the access of the catalytic site to PIP2 (Jones
and Wu, 2000). Consistent with these hypotheses, the in vitro
PLC activity of SFpH is 4- to 5-fold higher than that of SFC
(data not shown; also see Kurokawa et al., 2005). In addition,
in vitro assays revealed that the Ca2+ sensitivity of PLC
activity of SFC fractions was greatly enhanced by the presence
of PLCζ fragments (Kurokawa et al., 2005). Lastly, our
previous observation that after FPLC fractionation one of the
SFC fractions was mostly devoid of PLC- and [Ca2+]i
oscillation-inducing activity despite that 72-kDa PLCζ was
readily detectable (Kurokawa et al., 2005) supports the view
that modification of the X–Y linker domain affects PLCζ
activity.
Besides affording modulation of PLCζ function by
undergoing proteolysis, the X–Y linker domain may regulate
PLCζ function via other mechanisms. For instance, the
presence of extended charged amino acid repeats within this
region of PLCζ may facilitate interaction with other proteins
(Boehning et al., 2005), which may serve to further
modulate/protect PLCζ; these acidic repeats may also serve
as additional motifs for Ca2+ regulation (Haber-Pohlmeier et
al., 2007). Lastly, the presence in this domain of a conserved
stretch of positively charged amino acids, which serve as a
nuclear localization signal, is reportedly also required to
attain maximal enzymatic activity (Kuroda et al., 2006),
possibly by regulating the cellular distribution of the enzyme
and/or by favoring the interaction of the substrate with PLCζ(Heo et al., 2006; Nomikos et al., 2007). Importantly, it is
this last property that may be interfered with by the binding
of peptide A7 to PLCζ and that results in decrease in vitro
PLC activity of the enzyme. While presently we do not know
the site(s) of interaction between pPLCζ and peptide A7,
given that their interaction is likely underpinned by
complementary electrostatic charges and that the X–Y linker
region is enriched in charged residues, it is logical to
envision that peptide A7 is binding to this domain and that
this might interfere with the association/processing of the
substrate by PLCζ. Collectively, our results therefore support
the possibility that, in addition to being a target of
proteolysis, the X–Y linker domain may play other important
regulatory roles in the activity of PLCζ.
Does proteolytic cleavage of PLCζ play a role in mammalian
fertilization?
Whether or not proteolytic processing of PLCζ X–Y linker
domain plays a role in mammalian fertilization remains to be
determined. However, the finding that PLCζ fragments
consistent with enzyme cleavage in this region are observed
in fresh intact sperm and in sperm extracts, together with the
evidence that this cleavage may enhance the catalytic activity
of PLCζ, strengthens the possibility that processing of this
domain may play a role during mammalian fertilization. It is
important to note that, when whole sperm samples were
prepared for immunoblotting, the samples were handled such
that sperm retain motility until addition of the sample buffer,
greatly diminishing the possibility that the detected PLCζ
fragments were generated by our manipulations. To the best of
our knowledge, this is the first demonstration that functional
cleavage of a PLC actually takes place at the endogenous
levels.
In summary, our results show that PLCζ and/or its
complexed fragments account for all the [Ca2+]i oscillation-
inducing activity of porcine sperm/SFs as well as for all the
high-Ca2+ sensitive in vitro PLC activity of these fractions. Our
data also suggest that proteolytic processing of PLCζ may play
a role during fertilization and that the linker region of PLCζ,
which is likely the site of cleavage, may have several other
important regulatory functions. Lastly, given that the amino acid
sequence of the X–Y linker domain of PLCζ is poorly
conserved among species except for the presence of charged
amino acids, it is tempting to speculate that the different motifs
in this region may underlie the well-established species-specific
patterns of [Ca2+]i oscillations among mammals.
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